These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33772864)

  • 1. Utility of the pareidolia test in mild cognitive impairment with Lewy bodies and Alzheimer's disease.
    Hamilton CA; Matthews FE; Allan LM; Barker S; Ciafone J; Donaghy PC; Durcan R; Firbank MJ; Lawley S; O'Brien JT; Roberts G; Taylor JP; Thomas AJ
    Int J Geriatr Psychiatry; 2021 Sep; 36(9):1407-1414. PubMed ID: 33772864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease.
    Thomas AJ; Hamilton CA; Heslegrave A; Barker S; Durcan R; Lawley S; Barnett N; Lett D; Firbank M; Roberts G; Taylor JP; Donaghy PC; Zetterberg H; O'Brien J
    Mov Disord; 2022 Jul; 37(7):1495-1504. PubMed ID: 35318733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of autonomic symptoms may assist with early identification of mild cognitive impairment with Lewy bodies.
    Hamilton CA; Frith J; Donaghy PC; Barker SAH; Durcan R; Lawley S; Barnett N; Firbank M; Roberts G; Taylor JP; Allan LM; O'Brien J; Yarnall AJ; Thomas AJ
    Int J Geriatr Psychiatry; 2022 Apr; 37(4):. PubMed ID: 35302677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric profiles in mild cognitive impairment with Lewy bodies.
    Liu C; Liu S; Wang X; Ji Y
    Aging Ment Health; 2021 Nov; 25(11):2011-2017. PubMed ID: 32896168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies.
    Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; Colloby SJ; Lloyd J; Petrides G; McKeith IG; Thomas AJ
    Psychol Med; 2018 Oct; 48(14):2384-2390. PubMed ID: 29362011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis.
    Hamilton CA; Donaghy PC; Durcan R; Ciafone J; Olsen K; Roberts G; Firbank MJ; Allan LM; Taylor JP; O'Brien JT; Thomas AJ
    Neurology; 2024 Jul; 103(2):e209499. PubMed ID: 38870460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early differentiation of dementia with Lewy bodies and Alzheimer's disease: Heart rate variability at mild cognitive impairment stage.
    Kim MS; Yoon JH; Hong JM
    Clin Neurophysiol; 2018 Aug; 129(8):1570-1578. PubMed ID: 29883835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory impairment in mild cognitive impairment with Lewy bodies and Alzheimer's disease.
    Thomas AJ; Hamilton CA; Barker S; Durcan R; Lawley S; Barnett N; Firbank M; Roberts G; Allan LM; O'Brien J; Taylor JP; Donaghy PC
    Int Psychogeriatr; 2022 Jun; 34(6):585-592. PubMed ID: 34666863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies.
    Schumacher J; Taylor JP; Hamilton CA; Firbank M; Cromarty RA; Donaghy PC; Roberts G; Allan L; Lloyd J; Durcan R; Barnett N; O'Brien JT; Thomas AJ
    Alzheimers Res Ther; 2020 Jul; 12(1):82. PubMed ID: 32641111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood mRNA Expression in Alzheimer's Disease and Dementia With Lewy Bodies.
    Donaghy PC; Cockell SJ; Martin-Ruiz C; Coxhead J; Kane J; Erskine D; Koss D; Taylor JP; Morris CM; O'Brien JT; Thomas AJ
    Am J Geriatr Psychiatry; 2022 Sep; 30(9):964-975. PubMed ID: 35283023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
    van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
    Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms associated with Lewy body disease in mild cognitive impairment.
    Donaghy PC; Barnett N; Olsen K; Taylor JP; McKeith IG; O'Brien JT; Thomas AJ
    Int J Geriatr Psychiatry; 2017 Nov; 32(11):1163-1171. PubMed ID: 28556415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective predictors of decline
    Hamilton CA; Matthews FE; Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; McKeith IG; Thomas AJ
    Psychol Med; 2021 Nov; 51(15):2590-2598. PubMed ID: 32366348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency, Severity, and Duration of Autonomic Symptoms in Patients of Prodromal Dementia with Lewy Bodies.
    Liu S; Liu C; Hu W; Ji Y
    J Alzheimers Dis; 2022; 89(3):923-929. PubMed ID: 35988221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma biomarkers of neurodegeneration in mild cognitive impairment with Lewy bodies.
    Hamilton CA; O'Brien J; Heslegrave A; Laban R; Donaghy P; Durcan R; Lawley S; Barnett N; Roberts G; Firbank M; Taylor JP; Zetterberg H; Thomas A
    Psychol Med; 2023 Dec; 53(16):7865-7873. PubMed ID: 37489795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical symptoms in mild cognitive impairment with Lewy bodies: Frequency, time of onset, and discriminant ability.
    Donaghy PC; Hamilton C; Durcan R; Lawley S; Barker S; Ciafone J; Barnett N; Olsen K; Firbank M; Roberts G; Lloyd J; Allan LM; Saha R; McKeith IG; O'Brien JT; Taylor JP; Thomas AJ
    Eur J Neurol; 2023 Jun; 30(6):1585-1593. PubMed ID: 36912421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.
    Zhang B; Ferman TJ; Boeve BF; Smith GE; Maroney-Smith M; Spychalla AJ; Knopman DS; Jack CR; Petersen RC; Kantarci K
    J Neuroimaging; 2015; 25(2):269-274. PubMed ID: 25039916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD).
    Galvin JE; Chrisphonte S; Cohen I; Greenfield KK; Kleiman MJ; Moore C; Riccio ML; Rosenfeld A; Shkolnik N; Walker M; Chang LC; Tolea MI
    Alzheimers Dement; 2021 Oct; 17(10):1675-1686. PubMed ID: 33793069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile.
    Donaghy PC; Ciafone J; Durcan R; Hamilton CA; Barker S; Lloyd J; Firbank M; Allan LM; O'Brien JT; Taylor JP; Thomas AJ
    Psychol Med; 2022 Apr; 52(6):1147-1155. PubMed ID: 32840196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.